Danaher DHR
NYSE DHR
$227.56 -1.02 (-0.45%)
At close: Nov 19, 2026 · 4:02 PM EST

Danaher (DHR) Income from Continuing Operations (2009 - 2026)

Updated

Danaher (DHR) posted Income from Continuing Operations of $1.21 billion for Q3 2026, up 32.9% from $908 million a year earlier and up 38.7% from the prior quarter.

Analysis

Danaher (DHR) Income from Continuing Operations (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 25, 2026, Income from Continuing Operations at Danaher was $4.29 billion, up 22.4% year-over-year; for FY2025, it came in at $3.6 billion, down 7.7% from FY2024.

  • Annual Income from Continuing Operations has declined for three consecutive years, with a five-year compound annual growth rate of -0.3% (FY2020 to FY2025).
  • In prior years, Danaher's Income from Continuing Operations was $3.9 billion in FY2024 (-7.6%), $4.22 billion in FY2023 (-33.3%), $6.33 billion in FY2022 (+16.2%) and $5.45 billion in FY2021 (+49.4%).
  • The Q3 2026 figure stands as the highest quarterly Income from Continuing Operations since Q1 2023.
  • On a year-over-year basis, Income from Continuing Operations has increased in each of the last five quarters, with growth averaging 7.9% over the last eight quarters.
  • The strongest year-over-year quarter for Income from Continuing Operations in the past five years was Q4 2022, with growth of 126.6%; the weakest was Q4 2023, with a decline of 44.3%.
  • According to Business Quant data, Income from Continuing Operations for the three prior quarters was $870 million (Q2 2026), $1.03 billion (Q1 2026) and $1.18 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Thermo Fisher Scientific 247.92 Bn 224.44 Bn 5.13 Bn 1.74 Bn
2 Abbott Laboratories 178.73 Bn 152.60 Bn 7.39 Bn 920.00 Mn
3 Danaher 155.17 Bn 134.82 Bn 3.84 Bn 1.21 Bn
4 Intuitive Surgical 139.71 Bn 120.00 Bn 2.08 Bn 524.40 Mn
5 Medtronic 127.92 Bn 93.17 Bn 6.34 Bn 1.48 Bn
6 Stryker 118.34 Bn 104.53 Bn 4.25 Bn -237.00 Mn
7 Boston Scientific 61.10 Bn 56.53 Bn 3.43 Bn 580.00 Mn
8 Edwards Lifesciences 58.81 Bn 42.02 Bn 1.35 Bn 301.40 Mn
9 Agilent Technologies 47.86 Bn 40.75 Bn 1.04 Bn 362.00 Mn
10 Nuo Therapeutics 44.28 Bn 44.28 Bn 1.19 Mn -374,432.00
Historic Data

Historic Data

Download Data
DateValue
Sep 25, 2026 1.21 Bn
Jun 26, 2026 870.00 Mn
Mar 27, 2026 1.03 Bn
Dec 31, 2025 1.18 Bn
Sep 26, 2025 908.00 Mn
Jun 27, 2025 555.00 Mn
Mar 28, 2025 954.00 Mn
Dec 31, 2024 1.09 Bn
Sep 27, 2024 818.00 Mn
Jun 28, 2024 907.00 Mn
Mar 29, 2024 1.09 Bn
Dec 31, 2023 1.12 Bn
Sep 29, 2023 940.00 Mn
Jun 30, 2023 920.00 Mn
Mar 31, 2023 1.24 Bn
Dec 31, 2022 2.01 Bn
Sep 30, 2022 1.34 Bn
Jul 1, 2022 1.44 Bn
Apr 1, 2022 1.54 Bn
Dec 31, 2021 888.00 Mn
API Access

Danaher Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=DHR&period=max&api_key=YOUR_API_KEY